This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Strength Seen in ProDex (PDEX): Can Its 8.2% Jump Turn into More Strength?
by Zacks Equity Research
ProDex (PDEX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
PDEXPositive Net Change MCKPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Flexible Solutions International (FSI): Can Its 13.0% Jump Turn into More Strength?
by Zacks Equity Research
Flexible Solutions International (FSI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
FSIPositive Net Change MATVPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Okta (OKTA) Soars 3.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Okta (OKTA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
OKTAPositive Net Change SPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Strength Seen in Udemy (UDMY): Can Its 6.7% Jump Turn into More Strength?
by Zacks Equity Research
Udemy (UDMY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
UDMYNegative Net Change RBRKNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
PagerDuty (PD) Moves 6.9% Higher: Will This Strength Last?
by Zacks Equity Research
PagerDuty (PD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
PDNegative Net Change PHUNNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Should You Buy Alphabet Inc. (GOOG) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
GOOGPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
PENN Entertainment (PENN) Crossed Above the 20-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
PENNPositive Net Change
daily-movers moving-average-crossover stocks-moving-today
Shoals Technologies Group (SHLS) Just Overtook the 20-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
SHLSNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
Coeur Mining (CDE) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
CDEPositive Net Change
daily-movers moving-average-crossover stocks-moving-today
CERVOMED INC (CRVO) Surges 11.6%: Is This an Indication of Further Gains?
by Zacks Equity Research
CERVOMED INC (CRVO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CRVOPositive Net Change QGENPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Veracyte (VCYT) Soars 7.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Veracyte (VCYT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
VCYTPositive Net Change TMDXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Broadridge Financial (BR): Can Its 4.3% Jump Turn into More Strength?
by Zacks Equity Research
Broadridge Financial (BR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
BRNegative Net Change BRZEPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
SIGMA LITHIUM (SGML) Soars 6.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
SIGMA LITHIUM (SGML) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
SGMLPositive Net Change HAYWNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Bowman Consulting (BWMN) Soars 5.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Bowman Consulting (BWMN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
BWMNPositive Net Change ZIPPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Stevanato (STVN) Soars 10.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Stevanato (STVN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
STVNNegative Net Change ONCPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Coya Therapeutics, Inc. (COYA) Surges 10.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
Coya Therapeutics, Inc. (COYA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
COYANegative Net Change ABSINegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Raymond James Financial, Inc. (RJF) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
RJFPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
CryoPort, Inc. (CYRX) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
CYRXPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Alphabet (GOOGL) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
GOOGLPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Ur Energy (URG) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
URGNo Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, Envista (NVST)'s Technical Outlook is Bright
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
NVSTNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
City Office REIT (CIO) Surges 24.1%: Is This an Indication of Further Gains?
by Zacks Equity Research
City Office REIT (CIO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in FFO estimate revisions may not translate into further price increase in the near term.
CIONo Net Change LANDNo Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
scPharmaceuticals (SCPH) Soars 8.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
scPharmaceuticals (SCPH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
SCPHNegative Net Change CLDXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Tree.com (TREE) Surges 22.6%: Is This an Indication of Further Gains?
by Zacks Equity Research
Tree.com (TREE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
TREEPositive Net Change UWMCPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
HighPeak Energy (HPK) Moves 7.4% Higher: Will This Strength Last?
by Zacks Equity Research
HighPeak Energy (HPK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
HPKNegative Net Change GPORNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today